Last update 07 Nov 2024
Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride
Last update 07 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride, 盐酸西替利嗪/盐酸伪麻黄碱, Zyrtec-D |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists), α-adrenergic receptor agonists(Alpha adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (10 Aug 2001), |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC10H16ClNO |
InChIKeyBALXUFOVQVENIU-KXNXZCPBSA-N |
CAS Registry345-78-8 |
View All Structures (2)
Related
3
Clinical Trials associated with Cetirizine Hydrochloride/Pseudoephedrine HydrochlorideContac Bien Z Adverse Effect Survey
A Single-Dose Comparative Bioavailability Study of Two Formulations of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release Tablets Under Fasting Conditions
A Single-Dose Comparative Bioavailability Study of Two Formulations of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release Tablets Under Fed Conditions
100 Clinical Results associated with Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride
Login to view more data
100 Translational Medicine associated with Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride
Login to view more data
100 Patents (Medical) associated with Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride
Login to view more data
1
Literatures (Medical) associated with Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride01 Mar 2008Journal of the American Pharmacists Association : JAPhAQ4 · MEDICINE
OTC Product: Zyrtec and Zyrtec-D 12 hour
Q4 · MEDICINE
Article
Author: Bastianelli, Karen
100 Deals associated with Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Asthma | CN | 30 Dec 2005 | |
| Perennial allergic rhinitis with seasonal variation | US | 10 Aug 2001 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free